The FDA designated Abbott's recall of FreeStyle Libre 3 sensors as the most serious, class I type due to the risk for ...
If consumers find their sensor is from one of the affected ... Libre products such as the FreeStyle Libre 14 day, FreeStyle ...
Both of Abbott's over-the-counter CGMS are based on its popular FreeStyle Libre sensor technology ... It was designed for people with Type 2 diabetes and prediabetes in mind, so they can see ...
Tandem Diabetes Care (Nasdaq:TNDM) announced today that it received clearance for the use of rapid-acting insulin with its ...
Some better-ranked stocks in the broader medical space are TransMedix Group TMDX, Veracyte VCYT and Boston Scientific BSX. While TransMedix Group and Veracyte currently sport a Zacks Rank #1 (Strong ...
Abbott’s FreeStyle Libre devices involve a small sensor applied to the skin ... more than six million users who have type 1 or type 2 diabetes. She added that the collaboration provides people ...
Abbott introduced a revolutionary new device, FreeStyle Navigator, designed to improve the lives of the world’s more than 500 million diabetes patients by offering continuous glucose monitoring with ...
Earlier this year, Abbott integrated its FreeStyle Libre 2 Plus sensor with Tandem’s t:slim X2 insulin pump and Insulet received a CE mark for the integration of its Omnipod 5 pump with the company’s ...
The planned launch of Omnipod 5 with Abbott's Freestyle Libre 2 Plus sensor is likely to drive further growth in the U.S. markets.
DexCom's revised FY24 sales guidance in the Q2 earnings call led to a $18bn valuation reset. Read why I think DXCM stock is a ...
The planned launch of Omnipod 5 with Abbott's Freestyle Libre 2 Plus sensor is likely to drive further growth in the U.S. markets. Alcon, Inc. (NYSE: ALC) delivered core earnings per share of 74 ...
The results were further supported by data from continuous glucose monitoring (CGM; Freestyle Libre Pro iQ), which was used ... of measures of time above range, time in level 2 hyperglycemia, mean ...